Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2024 ▲▼ | Q2 2024 ▲▼ | Change ▲▼ | Q1 2024 ▲▼ | Q2 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Tarsus Pharmaceuticals, Inc.(TARS) | 2,254,797 | 2,254,797 | 0 | $81.96M | $61.29M | 6.24% | -$20.68M |
| Evolus, Inc.(EOLS) | 4,147,399 | 4,847,399 | +700,000 | $58.06M | $52.59M | 5.36% | -$5.47M |
| Kalvista Pharmaceuticals Inc | 4,125,345 | 4,218,829 | +93,484 | $48.93M | $49.70M | 5.06% | +$771.2K |
| Mirum Pharmaceuticals, Inc.(MIRM) | 1,187,107 | 1,287,107 | +100,000 | $29.82M | $44.01M | 4.48% | +$14.19M |
| Anaptysbio Inc | 1,330,879 | 1,330,879 | 0 | $29.97M | $33.35M | 3.40% | +$3.38M |
| ANI Pharmaceuticals, Inc.(ANIP) | 150,000 | 450,000 | +300,000 | $10.37M | $28.66M | 2.92% | +$18.29M |
| Dynavax Technologies Corp | 0 | 2,500,000 | +2,500,000 | $0 | $28.07M | 2.86% | +$28.07M |
| Eli Lilly and Company(LLY) | 27,000 | 27,000 | 0 | $21.00M | $24.45M | 2.49% | +$3.44M |
| Acadia Pharmaceuticals Inc | 518,900 | 1,500,000 | +981,100 | $9.59M | $24.38M | 2.48% | +$14.78M |
| Vaxcyte, Inc.(PCVX) | 300,000 | 300,000 | 0 | $20.49M | $22.65M | 2.31% | +$2.16M |
| PTC Therapeutics, Inc.(PTCT) | 700,000 | 700,000 | 0 | $20.36M | $21.41M | 2.18% | +$1.04M |
| Intra-Cellular Therapies Inc | 150,000 | 300,000 | +150,000 | $10.38M | $20.55M | 2.09% | +$10.17M |
| Altimmune, Inc.(ALT) | 2,750,000 | 2,750,000 | 0 | $28.00M | $18.29M | 1.86% | -$9.71M |
| Viridian Therapeutics, Inc.(VRDN) | 692,925 | 1,392,925 | +700,000 | $12.13M | $18.12M | 1.85% | +$5.99M |
| Avadel Pharmaceuticals Plc | 0 | 1,230,000 | +1,230,000 | $0 | $17.29M | 1.76% | +$17.29M |
| CRISPR Therapeutics AGNAMEN AKT(CRSP) | 116,500 | 316,500 | +200,000 | $7.94M | $17.09M | 1.74% | +$9.15M |
| Rocket Pharmaceuticals, Inc.(RCKT) | 660,000 | 750,000 | +90,000 | $17.78M | $16.15M | 1.64% | -$1.63M |
| Cullinan Therapeutics, Inc.(CGEM) | 571,138 | 921,138 | +350,000 | $9.73M | $16.06M | 1.64% | +$6.33M |
| Aurinia Pharmaceuticals Inc.(AUPH) | 2,050,000 | 2,779,500 | +729,500 | $10.27M | $15.87M | 1.62% | +$5.60M |
| GSK plcADR(GSK) | 300,000 | 400,000 | +100,000 | $12.86M | $15.40M | 1.57% | +$2.54M |
| Jazz Pharmaceuticals plcSHS USD(JAZZ) | 0 | 140,000 | +140,000 | $0 | $14.94M | 1.52% | +$14.94M |
| Atea Pharmaceuticals, Inc.(AVIR) | 4,076,741 | 4,476,741 | +400,000 | $16.47M | $14.82M | 1.51% | -$1.65M |
| NVIDIA Corporation(NVDA) | 10,000 | 115,019 | +105,019 | $9.04M | $14.21M | 1.45% | +$5.17M |
| Immunocore Holdings plcADS(IMCR) | 405,600 | 405,600 | 0 | $26.36M | $13.75M | 1.40% | -$12.62M |
| LENZ Therapeutics, Inc.(LENZ) | 547,616 | 747,616 | +200,000 | $12.23M | $12.93M | 1.32% | +$698.0K |
| Vanda Pharmaceuticals Inc.(VNDA) | 1,751,654 | 2,153,307 | +401,653 | $7.20M | $12.17M | 1.24% | +$4.97M |
| Outlook Therapeutics, Inc.(OTLK) | 1,619,412 | 1,619,412 | 0 | $19.34M | $11.95M | 1.22% | -$7.38M |
| AstraZeneca PLCADR(AZN) | 150,000 | 150,000 | 0 | $10.16M | $11.70M | 1.19% | +$1.54M |
| Kiniksa Pharmaceuticals International, plcCL A(KNSA) | 0 | 625,309 | +625,309 | $0 | $11.67M | 1.19% | +$11.67M |
| Nuvation Bio Inc.CL A(NUVB) | 3,551,864 | 3,751,864 | +200,000 | $12.93M | $10.96M | 1.12% | -$1.97M |
| Applied Therapeutics Inc | 2,230,000 | 2,330,000 | +100,000 | $15.16M | $10.88M | 1.11% | -$4.28M |
| Adicet Bio Inc | 6,407,400 | 8,216,960 | +1,809,560 | $15.06M | $9.94M | 1.01% | -$5.11M |
| Teladoc Health, Inc.(TDOC) | 0 | 1,000,000 | +1,000,000 | $0 | $9.78M | 1.00% | +$9.78M |
| CytomX Therapeutics, Inc.(CTMX) | 6,450,000 | 7,791,936 | +1,341,936 | $14.06M | $9.51M | 0.97% | -$4.55M |
| Cargo Therapeutics Inc | 466,809 | 572,697 | +105,888 | $10.42M | $9.40M | 0.96% | -$1.02M |
| Zymeworks Inc.(ZYME) | 1,100,000 | 1,100,000 | 0 | $11.57M | $9.36M | 0.95% | -$2.21M |
| Immunome, Inc.(IMNM) | 720,000 | 720,000 | 0 | $17.77M | $8.71M | 0.89% | -$9.06M |
| Harmony Biosciences Holdings, Inc.(HRMY) | 281,200 | 281,200 | 0 | $9.44M | $8.48M | 0.86% | -$958.9K |
| Elevation Oncology Inc | 3,060,000 | 3,060,000 | 0 | $15.70M | $8.26M | 0.84% | -$7.44M |
| Biogen Inc.(BIIB) | 0 | 35,000 | +35,000 | $0 | $8.11M | 0.83% | +$8.11M |
| Black Diamond Therapeutics I | 1,603,200 | 1,603,200 | 0 | $8.13M | $7.47M | 0.76% | -$657.3K |
| Replimune Group, Inc.(REPL) | 0 | 805,440 | +805,440 | $0 | $7.25M | 0.74% | +$7.25M |
| Ventyx Biosciences Inc | 3,100,000 | 3,100,000 | 0 | $17.05M | $7.16M | 0.73% | -$9.89M |
| Ionis Pharmaceuticals, Inc.(IONS) | 150,000 | 150,000 | 0 | $6.50M | $7.15M | 0.73% | +$646.5K |
| Dianthus Therapeutics, Inc.(DNTH) | 264,692 | 264,692 | 0 | $7.94M | $6.85M | 0.70% | -$1.09M |
| Insmed Incorporated(INSM) | 0 | 100,000 | +100,000 | $0 | $6.70M | 0.68% | +$6.70M |
| Heron Therapeutics, Inc.(HRTX) | 1,850,000 | 1,850,000 | 0 | $5.12M | $6.47M | 0.66% | +$1.35M |
| Viking Therapeutics, Inc.(VKTX) | 100,000 | 120,000 | +20,000 | $8.20M | $6.36M | 0.65% | -$1.84M |
| Beam Therapeutics Inc.(BEAM) | 0 | 270,000 | +270,000 | $0 | $6.33M | 0.64% | +$6.33M |
| Precision BioSciences, Inc.(DTIL) | 589,569 | 623,332 | +33,763 | $7.99M | $6.07M | 0.62% | -$1.93M |
| Merus N V | 0 | 100,000 | +100,000 | $0 | $5.92M | 0.60% | +$5.92M |
| Meta Platforms, Inc.CL A(META) | 10,000 | 11,396 | +1,396 | $4.86M | $5.75M | 0.59% | +$890.2K |
| Structure Therapeutics IncADS | 100,000 | 144,500 | +44,500 | $4.29M | $5.67M | 0.58% | +$1.39M |
| Marinus Pharmaceuticals Inc | 0 | 4,800,000 | +4,800,000 | $0 | $5.62M | 0.57% | +$5.62M |
| Cytokinetics, Incorporated(CYTK) | 100,000 | 100,000 | 0 | $7.01M | $5.42M | 0.55% | -$1.59M |
| BeOne Medicines AGADR(ONC) | 37,000 | 37,000 | 0 | $5.79M | $5.28M | 0.54% | -$507.6K |
| Design Therapeutics, Inc.(DSGN) | 1,480,975 | 1,480,975 | 0 | $5.97M | $4.96M | 0.51% | -$1.01M |
| BioCryst Pharmaceuticals, Inc.(BCRX) | 800,000 | 800,000 | 0 | $4.06M | $4.94M | 0.50% | +$880.0K |
| Biohaven Ltd.(BHVN) | 140,000 | 140,000 | 0 | $7.66M | $4.86M | 0.49% | -$2.80M |
| Arvinas, Inc.(ARVN) | 180,000 | 180,000 | 0 | $7.43M | $4.79M | 0.49% | -$2.64M |
| Alexandria Real Estate Eq In | 0 | 40,000 | +40,000 | $0 | $4.68M | 0.48% | +$4.68M |
| Reneo Pharmaceuticals Inc | 2,997,000 | 2,996,260 | -740 | $4.98M | $4.52M | 0.46% | -$450.7K |
| Liquidia Corporation(LQDA) | 150,000 | 350,000 | +200,000 | $2.21M | $4.20M | 0.43% | +$1.99M |
| Lantheus Holdings, Inc.(LNTH) | 50,000 | 50,000 | 0 | $3.11M | $4.01M | 0.41% | +$902.5K |
| Iovance Biotherapeutics, Inc.(IOVA) | 500,000 | 500,000 | 0 | $7.41M | $4.01M | 0.41% | -$3.40M |
| Apogee Therapeutics Inc | 100,000 | 100,000 | 0 | $6.64M | $3.94M | 0.40% | -$2.71M |
| Enanta Pharmaceuticals, Inc.(ENTA) | 300,000 | 300,000 | 0 | $5.24M | $3.89M | 0.40% | -$1.35M |
| Seer, Inc.CL A(SEER) | 674,125 | 2,300,000 | +1,625,875 | $1.28M | $3.86M | 0.39% | +$2.58M |
| Nkarta, Inc.(NKTX) | 550,000 | 550,000 | 0 | $5.95M | $3.25M | 0.33% | -$2.69M |
| Bolt Biotherapeutics Inc | 3,420,000 | 3,812,773 | +392,773 | $4.79M | $2.86M | 0.29% | -$1.93M |
| Mirum Pharmaceuticals, Inc.NOTE 4 000 5 0(MIRM) | 0 | 0 | 0 | $0 | $2.83M | 0.29% | +$2.83M |
| Athira Pharma Inc | 852,715 | 1,052,715 | +200,000 | $2.34M | $2.79M | 0.28% | +$453.3K |
| Genmab A/SADS(GMAB) | 100,000 | 100,000 | 0 | $2.99M | $2.51M | 0.26% | -$478.0K |
| Inhibrx Biosciences, Inc.(INBX) | 0 | 167,500 | +167,500 | $0 | $2.37M | 0.24% | +$2.37M |
| Fate Therapeutics, Inc.(FATE) | 700,000 | 700,000 | 0 | $5.14M | $2.30M | 0.23% | -$2.84M |
| Century Therapeutics, Inc.(IPSC) | 900,000 | 900,000 | 0 | $3.76M | $2.29M | 0.23% | -$1.47M |
| Douglas Emmett, Inc.(DEI) | 0 | 171,138 | +171,138 | $0 | $2.28M | 0.23% | +$2.28M |
| Kura Oncology, Inc.(KURA) | 100,000 | 100,000 | 0 | $2.13M | $2.06M | 0.21% | -$74.0K |
| BioAtla, Inc.(BCAB) | 1,474,076 | 1,374,076 | -100,000 | $5.07M | $1.88M | 0.19% | -$3.19M |
| Coherus Oncology, Inc.(CHRS) | 0 | 1,050,000 | +1,050,000 | $0 | $1.82M | 0.19% | +$1.82M |
| TG Therapeutics, Inc.(TGTX) | 100,000 | 100,000 | 0 | $1.52M | $1.78M | 0.18% | +$258.0K |
| Seres Therapeutics, Inc.(MCRB) | 907,112 | 2,407,112 | +1,500,000 | $702.2K | $1.74M | 0.18% | +$1.04M |
| Adaptimmune Therapeutics plcADR(ADAPY) | 1,443,619 | 1,743,619 | +300,000 | $2.28M | $1.70M | 0.17% | -$581.1K |
| Verastem, Inc.(VSTM) | 541,514 | 541,514 | 0 | $6.39M | $1.61M | 0.16% | -$4.78M |
| Lakefront Biotherapeutics NVADR(LKFT) | 0 | 55,609 | +55,609 | $0 | $1.38M | 0.14% | +$1.38M |
| AbCellera Biologics Inc.(ABCL) | 0 | 461,699 | +461,699 | $0 | $1.37M | 0.14% | +$1.37M |
| Tectonic Therapeutic, Inc.(TECX) | 0 | 79,166 | +79,166 | $0 | $1.30M | 0.13% | +$1.30M |
| Erasca, Inc.(ERAS) | 100,000 | 550,000 | +450,000 | $206.0K | $1.30M | 0.13% | +$1.09M |
| Passage Bio, Inc.(PASG) | 1,500,000 | 1,500,000 | 0 | $2.02M | $1.19M | 0.12% | -$833.7K |
| OmniAb, Inc.(OABI) | 0 | 300,000 | +300,000 | $0 | $1.13M | 0.11% | +$1.13M |
| IRulya Therapeutics Inc.(IRLA) | 2,947,652 | 1,500,000 | -1,447,652 | $3.12M | $1.13M | 0.11% | -$2.00M |
| Atyr Pharma Inc | 471,134 | 671,134 | +200,000 | $918.7K | $1.05M | 0.11% | +$128.3K |
| Revance Therapeutics Inc | 200,000 | 400,000 | +200,000 | $984.0K | $1.03M | 0.10% | +$44.0K |
| Nextcure Inc | 144,520 | 602,994 | +458,474 | $322.3K | $958.8K | 0.10% | +$636.5K |
| MacroGenics, Inc.(MGNX) | 0 | 218,856 | +218,856 | $0 | $930.1K | 0.09% | +$930.1K |
| C4 Therapeutics, Inc.(CCCC) | 0 | 200,000 | +200,000 | $0 | $924.0K | 0.09% | +$924.0K |
| Astria Therapeutics Inc | 0 | 100,000 | +100,000 | $0 | $910.0K | 0.09% | +$910.0K |
| Journey Medical Corporation(DERM) | 138,625 | 148,322 | +9,697 | $510.1K | $836.5K | 0.09% | +$326.4K |
| Relmada Therapeutics, Inc.(RLMD) | 382 | 237,874 | +237,492 | $1.8K | $713.6K | 0.07% | +$711.8K |
| Tyra Biosciences, Inc.(TYRA) | 0 | 42,223 | +42,223 | $0 | $675.1K | 0.07% | +$675.1K |